Insider trades
Sharon Benzeno, Chief Officer of Adaptive Biotechnologies ADPT, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $14.7M. The latest trade was on 06/29.
Sharon Benzeno
Chief Commercial Ofc Imm Med
- First filing
- 23/03/08
- Trades
- 50 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$14.7M
- Last trade
- 06/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADPT | Open-market sale10b5-1 plan | 06/26–06/29 | 06/30 | 165,802 sh2 trades | $21.13avg. | $3,503,509.52 | −42.8% |
| Open-market sale | 03/11 | 03/13 | 63,103 sh | $13.17 | $831,066.51 | −18.8% | |
| Open-market sale10b5-1 plan | 25/12/04 | 25/12/08 | 12,604 sh | $16.85 | $212,377.4 | −4.1% | |
ADPT | Open-market sale10b5-1 plan | 25/11/20–25/11/21 | 25/11/24 | 606,402 sh2 trades | $16.73avg. | $10,144,025.57 | −67.1% |
ADPT | Open-market sale | 25/03/05 | 25/03/06 | 44,665 sh2 trades | $6.98avg. | $311,792.35 | −10.2% |
ADPT | Open-market sale | 24/03/05 | 24/03/06 | 29,390 sh2 trades | $3.44avg. | $100,994.14 | −8.2% |
| Open-market sale | 23/03/06 | 23/03/08 | 11,749 sh | $8.57 | $100,688.93 | −5.0% |